Thus, we treated ZM-transformed AML cell lines with I-BET151, a selective Brd4/BET inhibitor41, and found that, I-BET151 treatment efficiently blocked AML cell proliferation and elevated cell death (Fig. 7c). Here, BRD4 is linked to acute myeloid leukemia.